Balchem agrees to acquire vitamin K2 player Kappa Bioscience
New York-based Balchem Corporation has signed a definitive agreement to acquire Norwegian Vitamin K2 supplier Kappa Bioscience AS for approximately US$340 million.
Archives for June 14, 2022